How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
The U.S. Patent Office rejected a patent that would have covered methods of making certain antibodies or antibody fragments, saying it was similar to a Genentech patent that expires in '06. S&P Equity still upgraded the firm's rating to strong buy. Shares rose 4.5%...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
